Fecal Microbiota Transplantation
Trials 42
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 05 trials · 1 met primary | ||||||
| Phase 0 | NCT07683936 | Jun 2026 → Jan 2027 expected | hepatic encephalopathy | Air Force Military Medical University, China | Recruiting | No outcome recorded |
| Phase 0 | NCT07003438 | Jun 2025 → Apr 2026 overdue | steroid-resistant nephrotic syndrome | Zhang Ting | Not yet recruiting | No outcome recorded |
| Phase 0 | NCT05598112 | Apr 2023 → Dec 2026 expected | — | Chinese Academy of Medical Sciences, Fuwai Hospital | Recruiting | No outcome recorded |
| Phase 0 | NCT04975217 | Dec 2021 → Dec 2026 | pancreatic ductal adenocarcinoma | M.D. Anderson Cancer Center | Suspended | No outcome recorded |
| Phase 0 | NCT02733744 | May → Dec 2016 | — | Massachusetts General Hospital | Completed | Met primary |
| Phase 17 trials · 1 met primary | ||||||
| Phase 1 | NCT05067595 | Jan 2025 → Dec 2027 expected | graft versus host disease | Fred Hutchinson Cancer Center | Recruiting | No outcome recorded |
| Phase 1 | NCT05911997 | Jan 2024 → Nov 2025 | Clostridium difficile colitis | Icahn School of Medicine at Mount Sinai | Completed | Met primary |
| Phase 1 | NCT03747718 | Dec 2022 → Dec 2024 | Crohn disease | Stanford University | Withdrawn | No outcome recorded Stop: Business |
| Phase 1 | NCT06368895 | Apr 2021 → Jun 2024 | hepatic encephalopathy, immune dysregulation, neurodevelopmental defects, and colitis | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Completed | No outcome recorded |
| Phase 1 | NCT03087097 | Apr 2019 → Jul 2020 | protein-energy malnutrition | Microbiome Health Research Institute | Terminated | No outcome recorded |
| Phase 1 | NCT02469272 | May 2015 → Jun 2018 | NAFLD1 | Lifespan | Unknown | No outcome recorded |
| Phase 1 | NCT02399618 | Mar 2015 → Sep 2016 | Clostridium infectious disease | Jinling Hospital, China | Unknown | No outcome recorded |
| Phase 1/23 trials | ||||||
| Phase 1/2 | NCT07628777 | Jun 2026 → Mar 2027 expected | heart failure | The First Affiliated Hospital of Air Force Medicial University | Not yet recruiting | No outcome recorded |
| Phase 1/2 | NCT07454408 | Mar 2026 → Jun 2028 expected | hepatic encephalopathy | Air Force Military Medical University, China | Not yet recruiting | No outcome recorded |
| Phase 1/2 | NCT03167398 | Feb 2018 → Dec 2019 | — | Rambam Health Care Campus | Completed | No outcome recorded |
| Phase 28 trials · 1 met primary · 1 missed | ||||||
| Phase 2 | NCT07756255 | Aug 2026 → Aug 2028 expected | attention deficit-hyperactivity disorder | University of Calgary | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT07477782 | May 2026 → Apr 2029 expected | inflammatory bowel disease, primary sclerosing cholangitis | Assistance Publique - Hôpitaux de Paris | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT06563947 | Sep 2024 → May 2027 expected | hepatocellular carcinoma | Xu Yong, MD | Recruiting | No outcome recorded |
| Phase 2 | NCT06218602 | Feb 2024 → Aug 2026 overdue | lymphoma | M.D. Anderson Cancer Center | Recruiting | No outcome recorded |
| Phase 2 | NCT04059757 | May 2022 → Jun 2023 | acute graft versus host disease | Leland Metheny | Withdrawn | No outcome recorded |
| Phase 2 | NCT04760665 | Oct 2021 → Nov 2023 | — | Maimónides Biomedical Research Institute of Córdoba | Terminated | No outcome recorded |
| Phase 2 | NCT03998488 | Jan 2020 → Jun 2023 | ulcerative colitis | Weill Medical College of Cornell University | Completed | Met primary |
| Phase 2 | NCT02328547 | May 2015 → Oct 2017 | irritable bowel syndrome | Montefiore Medical Center | Completed | Missed primary |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT06603883 | Oct 2024 → Mar 2026 | intestinal dysmotility syndrome | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Completed | No outcome recorded |
| Phase 35 trials | ||||||
| Phase 3 | NCT06433180 | Jul 2025 → Jul 2028 expected | irritable bowel syndrome | Assistance Publique - Hôpitaux de Paris | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT05266807 | Mar 2023 → Apr 2027 expected | Clostridium difficile colitis | Benoit Guery | Recruiting | No outcome recorded |
| Phase 3 | NCT02801656 | Dec 2020 → Sep 2022 | Clostridium difficile colitis | Memorial University of Newfoundland | Withdrawn | No outcome recorded Stop: Business |
| Phase 3 | NCT03483246 | Sep 2018 → Sep 2025 overdue | ulcerative colitis | Assistance Publique - Hôpitaux de Paris | Active not recruiting | No outcome recorded |
| Phase 3 | NCT03819803 | Mar 2017 → Mar 2026 overdue | acute graft versus host disease | Medical University of Graz | Recruiting | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT02998112 | Dec 2016 → Jul 2017 | ulcerative colitis | The Second Hospital of Nanjing Medical University | Unknown | No outcome recorded |
| Phase not applicable12 trials | ||||||
| — | NCT07599046 | Apr 2026 → Jan 2027 expected | type 2 diabetes mellitus | Eighth Affiliated Hospital, Sun Yat-sen University | Not yet recruiting | No outcome recorded |
| — | NCT07464392 | Apr 2026 → Jul 2027 expected | acute pancreatitis | Changhai Hospital | Recruiting | No outcome recorded |
| — | NCT07746635 | Apr 2025 → Dec 2028 expected | polycystic ovary syndrome | Shanghai Changzheng Hospital | Recruiting | No outcome recorded |
| — | NCT06388863 | Feb 2025 → Dec 2026 expected | Parkinson disease | Shanghai Zhongshan Hospital | Recruiting | No outcome recorded |
| — | NCT06475430 | Jan 2025 → Jun 2026 overdue | — | Peking University People's Hospital | Not yet recruiting | No outcome recorded |
| — | NCT06333405 | May 2024 → Jan 2025 | necrotizing enterocolitis | Medical University of Warsaw | Unknown | No outcome recorded |
| — | NCT05850585 | Jul 2023 → Dec 2025 overdue | schizophrenia | First Affiliated Hospital Xi'an Jiaotong University | Not yet recruiting | No outcome recorded |
| — | NCT05850572 | Jul 2023 → Dec 2025 overdue | depressive disorder | First Affiliated Hospital Xi'an Jiaotong University | Not yet recruiting | No outcome recorded |
| — | NCT05838118 | Apr 2023 → Dec 2024 | chronic kidney disease | The Second Hospital of Nanjing Medical University | Unknown | No outcome recorded |
| — | NCT05427331 | Jun 2022 → May 2023 | insomnia | Third Military Medical University | Unknown | No outcome recorded |
| — | NCT04861649 | Mar 2021 → Jun 2023 | — | Shanghai Asclepius Meditec Inc. | Unknown | No outcome recorded |
| — | NCT03058900 | May 2017 → Jun 2020 | psoriatic arthritis | Odense University Hospital | Completed | No outcome recorded |
| Comparator or background therapy7 trials | ||||||
| Phase 0 | NCT04968951 Comparator | Nov 2021 → Aug 2022 | ulcerative colitis | Ari M Grinspan | Terminated | No outcome recorded Stop: Business |
| Phase 1/2 | NCT02741518 Comparator | Apr 2017 → Oct 2018 | obesity disorder | Brigham and Women's Hospital | Completed | No outcome recorded |
| Phase 2 | NCT02346669 Comparator | Apr 2016 → Jan 2018 | obesity disorder, type 2 diabetes mellitus | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| Phase 2 | NCT02557685 Comparator | Jun 2015 → Mar 2016 | Clostridium difficile colitis | The Miriam Hospital | Unknown | No outcome recorded |
| Phase 2 | NCT01703494 Comparator | Oct 2012 → May 2015 | Clostridium difficile colitis | Colleen Kelly | Unknown | No outcome recorded |
| — | NCT06744751 Comparator | Sep 2025 → Dec 2026 expected | anorexia nervosa | Shanghai Mental Health Center | Not yet recruiting | No outcome recorded |
| — | NCT03766321 Comparator | Jul 2020 → Feb 2025 | amyotrophic lateral sclerosis | University Hospital of Modena | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 52 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fecal microbiota transplantation | “Following promising results in autism spectrum disorder, fecal microbiota transplantation (FMT) presents a novel approach to address symptom management in ADHD.” NCT07756255 ↗48“Effect of Fecal Microbiota Transplantation on Aging and the Underlying Mechanism of Gut Microbiome Restoration: a Randomized Clinical Trial” NCT05598112 ↗ “Participants will be treated with healthy donor-derived fecal microbiota transplantation in the form of oral capsules.” NCT06388863 ↗ “Objective: To investigate whether Fecal Microbiota Transplantation(FMT) can improve sleep in patients with insomnia” NCT05427331 ↗ |
| Known as | faecal microbiota transplantation | “Faecal microbiota transplantation (FMT) could be an effective and safe strategy to decolonise intestinal carriers of KPC-producing Klebsiella pneumoniae (KPC-Kp)” PMID 35387830 ↗ Apr 2022 |
| Known as | FMT | “This prospective, single-center, single-arm phase 2 study evaluates the efficacy and safety of adding oral fecal microbiota transplantation (FMT) capsules to continued immune...” NCT06563947 ↗24“A randomised, placebo-controlled trial of faecal microbiota transplantation (FMT) infused into the small intestine of patients with PsA with active peripheral disease who are...” PMID 29703851 ↗ Apr 2018 “The process of fecal microbiota transplantation FMT, where fecal microbial community from a healthy individual is transferred into a recipient, has been established as an...” NCT03747718 ↗ “Fecal microbiota transplantation (FMT) is a novel, safe, convenient therapeutic treatment which transplant gut microbiota from donor to patient to rebuild a gut microecology.” NCT05838118 ↗ “Fecal microbiota transplantation (FMT), given as oral capsules, compared with placebo for the treatment of refractory diarrhea-predominant irritable bowel syndrome (IBS-D)” NCT02328547 ↗ “Fecal Microbiota Transplantation (FMT) is the transfer of fecal material from a healthy donor to a patient in order to restore the diversity of the intestinal microbiota.” NCT04059757 ↗ “Fecal microbiota transplant (FMT) is an effective therapy for recurrent Clostridioides difficile infection (rCDI) but has undefined composition and poor scalability.” PMID 42230754 ↗ Jun 2026 “Following promising results in autism spectrum disorder, fecal microbiota transplantation (FMT) presents a novel approach to address symptom management in ADHD.” NCT07756255 ↗ “Fecal microbiota transplantation (FMT), in which fecal material enriched with commensal microorganisms is transferred from a healthy donor” NCT03167398 ↗ “The clinical trial aims to evaluate the efficacy of fecal microbiota transplantation (FMT) after standard of care treatment” NCT05266807 ↗ “Objective: To investigate whether Fecal Microbiota Transplantation(FMT) can improve sleep in patients with insomnia” NCT05427331 ↗ |
| Known as | FMT, stool transplant | “FMT, stool transplant” NCT02557685 ↗ |
| Known as | MBiotix HBI | “Fecal Microbiota as a suspension obtained from healthy unrelated donor (woman in 3rd trimester of pregnancy) introduced two times per treatment: * as a deep rectal infusion,...” NCT06333405 ↗ |
| Action | Restore | “to restore missing components of normal intestinal flora” NCT01703494 ↗ |
| Modality | Other / unclassified | “Fecal microbiota transplant from healthy, unrelated donor via freeze-dried capsule” NCT02399618 ↗ |
| Route | Other | “delivered via colonoscopy” NCT01703494 ↗ |